Biology of Sexually Transmitted Diseases

 The global market for biology of sexually transmitted diseases was valued at $33.3 billion in 2012 and the total market net worth is envisaged to reach $52 billion in 2017 at a CAGR of about 9.3%.

STDs, or rather STIs (Sexually Transmitted Infections) hold a crucial global health prominence because of their overwhelming - emotional, mental and physical impact on women and in infants. Infections with few STDs can accentuate the risk of contracting and transmitting HIV and modify the course of the disease progression. Besides, STDs can also cause chronic health implications, notably in women and infants. Some of the health implications of STDs comprises of cervical cancer, infertility, pelvic inflammatory disease, tubal or ectopic pregnancy and perinatal or congenital infections in infants born to indisposed mothers. A sexually transmitted disease (STD), also called venereal diseases (VD), is a disease which typically transmits through some form of sexual contact, but not necessarily only this mode of transmission. STDs can also be transmitted from infected blood transfusion, from mother to child or also through transmission of bodily fluids, but commonly by sex, especially vaginal intercourse, anal sex and oral sex. As most STIs initially are asymptomatic, which result in an augmented outcome of transmitting the disease to others. Most STIs are treatable or curable; but herpes, hepatitis B, HIV/AIDS, and HPV are only treatable but not curable. 

  • Contraction and Transmission of STD
  • Viral cause of STD
  • Health complications in Male and female
  • Countermeasures and Prevention

Related Conference of Biology of Sexually Transmitted Diseases

Biology of Sexually Transmitted Diseases Conference Speakers